253 related articles for article (PubMed ID: 30913953)
1. Endometriosis-associated ovarian cancer is a single entity with distinct clinicopathological characteristics.
Li Q; Sun Y; Zhang X; Wang L; Wu W; Wu M; Meng C; Liu G
Cancer Biol Ther; 2019; 20(7):1029-1034. PubMed ID: 30913953
[No Abstract] [Full Text] [Related]
2. Endometriosis-associated Ovarian Cancer: A Distinct Clinical Entity?
Bounous VE; Ferrero A; Fuso L; Ravarino N; Ceccaroni M; Menato G; Biglia N
Anticancer Res; 2016 Jul; 36(7):3445-9. PubMed ID: 27354606
[TBL] [Abstract][Full Text] [Related]
3. Endometriosis-associated ovarian carcinoma (EAOC): an entity distinct from other ovarian carcinomas as suggested by a nested case-control study.
Erzen M; Rakar S; Klancnik B; Syrjänen K
Gynecol Oncol; 2001 Oct; 83(1):100-8. PubMed ID: 11585420
[TBL] [Abstract][Full Text] [Related]
4. Endometriosis-associated ovarian cancer is not a distinct clinical entity among young patients: A 12-year cohort study.
Cai Y; Yin J; Jin Y; Li Y; Wu M; Yang J; Huang H; Leng J; Pan L
Eur J Surg Oncol; 2020 May; 46(5):876-882. PubMed ID: 31837932
[TBL] [Abstract][Full Text] [Related]
5. Endometriosis-associated Ovarian Cancer is a Subset With a More Favorable Outcome and Distinct Clinical-pathologic Characteristics.
Bassiouny D; El-Baz MA; Gamil TM; Shams N; Ismiil N; Dubé V; Han G; Cesari M; Lu FI; Slodkowska E; Chiu HF; Naeim M; Li N; Nofech-Mozes S; Khalifa MA
Int J Gynecol Pathol; 2019 Sep; 38(5):435-442. PubMed ID: 30059454
[TBL] [Abstract][Full Text] [Related]
6. Unraveling the two entities of endometrioid ovarian cancer: a single center clinical experience.
Mangili G; Bergamini A; Taccagni G; Gentile C; Panina P; Viganò P; Candiani M
Gynecol Oncol; 2012 Sep; 126(3):403-7. PubMed ID: 22609111
[TBL] [Abstract][Full Text] [Related]
7. The effect of concurrent endometriosis on the prognosis of women with ovarian clear cell or endometrioid carcinoma.
Ju UC; Kang WD; Kim SM
Int J Gynaecol Obstet; 2019 Aug; 146(2):177-183. PubMed ID: 31081117
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of endometriosis in patients with stage I ovarian clear cell carcinoma: Experiences at three academic institutions.
Bai H; Cao D; Yuan F; Sha G; Yang J; Chen J; Wang Y; Zhang Z; Shen K
Gynecol Oncol; 2016 Dec; 143(3):526-531. PubMed ID: 27745918
[TBL] [Abstract][Full Text] [Related]
9. Clinical outcomes of patients with clear cell and endometrioid ovarian cancer arising from endometriosis.
Paik ES; Kim TJ; Choi CH; Kim BG; Bae DS; Lee JW
J Gynecol Oncol; 2018 Mar; 29(2):e18. PubMed ID: 29400011
[TBL] [Abstract][Full Text] [Related]
10. Risk and prognosis of ovarian cancer in women with endometriosis: a meta-analysis.
Kim HS; Kim TH; Chung HH; Song YS
Br J Cancer; 2014 Apr; 110(7):1878-90. PubMed ID: 24518590
[TBL] [Abstract][Full Text] [Related]
11. [Risk factors of endometriosis associated ovarian carcinoma in women aged 45 years and older].
He ZX; Wang S; Li ZF; Zhu L; Leng JH; Lang JH
Zhonghua Fu Chan Ke Za Zhi; 2017 May; 52(5):314-319. PubMed ID: 28545269
[No Abstract] [Full Text] [Related]
12. Predictive factors of ovarian carcinoma for women with ovarian endometrioma aged 45 years and older in China.
He ZX; Shi HH; Fan QB; Zhu L; Leng JH; Sun DW; Li ZF; Shen K; Wang S; Lang JH
J Ovarian Res; 2017 Jul; 10(1):45. PubMed ID: 28716151
[TBL] [Abstract][Full Text] [Related]
13. Differentiation between endometriosis-associated ovarian cancers and non- endometriosis-associated ovarian cancers based on magnetic resonance imaging.
Zhang X; Li M; Tang Z; Li X; Song T
Br J Radiol; 2021 Sep; 94(1125):20201441. PubMed ID: 33882252
[TBL] [Abstract][Full Text] [Related]
14. [Expression and significance of GLI1 and Shh in the malignant transformation of ovarian endometriosis].
Zhao F; Yu XP; Zhao H; Song BB; Lyu AW; Zhang SH; Wang LM
Zhonghua Fu Chan Ke Za Zhi; 2022 Feb; 57(2):125-132. PubMed ID: 35184473
[No Abstract] [Full Text] [Related]
15. Evidence for the Relationship Between Endometriosis and Epithelial Ovarian Cancer.
del Carmen MG
Obstet Gynecol Surv; 2015 Sep; 70(9):587-95. PubMed ID: 26403563
[TBL] [Abstract][Full Text] [Related]
16. ADP-ribosylation factor-like 4C predicts worse prognosis in endometriosis-associated ovarian cancers.
Wakinoue S; Chano T; Amano T; Isono T; Kimura F; Kushima R; Murakami T
Cancer Biomark; 2019; 24(2):223-229. PubMed ID: 30594917
[TBL] [Abstract][Full Text] [Related]
17. Is the presence of endometriosis associated with a survival benefit in pure ovarian clear cell carcinoma?
Sahin H; Sari ME; Cuylan ZF; Haberal AN; Sirvan L; Coban G; Yalcin I; Güngör T; Celik H; Meydanli MM; Ayhan A
Arch Gynecol Obstet; 2018 Apr; 297(4):1005-1013. PubMed ID: 29383437
[TBL] [Abstract][Full Text] [Related]
18. Histologic Subtypes in Endometriosis-Associated Ovarian Cancer and Ovarian Cancer Arising in Endometriosis: A Systematic Review and Meta-Analysis.
Chiaffarino F; Cipriani S; Ricci E; Esposito G; Parazzini F; Vercellini P
Reprod Sci; 2024 Jun; 31(6):1642-1650. PubMed ID: 38438776
[TBL] [Abstract][Full Text] [Related]
19. Abundance of mitochondrial superoxide dismutase is a negative predictive biomarker for endometriosis-associated ovarian cancers.
Amano T; Chano T; Isono T; Kimura F; Kushima R; Murakami T
World J Surg Oncol; 2019 Jan; 17(1):24. PubMed ID: 30700285
[TBL] [Abstract][Full Text] [Related]
20. The association between endometriosis and survival outcomes of ovarian cancer: Evidence-based on a meta-analysis.
Yang B; Wang D; Chen H; Yang F
Niger J Clin Pract; 2015; 18(5):577-83. PubMed ID: 26096232
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]